Home > Insider Trading > Filing (0001144204-11-004050)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1419701	L.p. Partners Venture Longitude	800 El Camino Real, Suite 220 Menlo Park CA 94025	Yes	No	Yes	No
1430719	Longitude Capital Associates, L.p.	800 El Camino Real, Suite 220 Menlo Park CA 94025	Yes	No	Yes	No
1430720	Longitude Capital Partners, Llc	800 El Camino Real, Suite 220 Menlo Park CA 94025	Yes	No	Yes	No
1431159	Juliet Bakker Tammenoms	800 El Camino Real, Suite 220 Menlo Park CA 94025	Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-21	750,000	$3.90	12,576,929	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Longitude Venture Partners, L.P. ("LVP") may be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. LVP is the record holder of 735,263 shares of common stock and Longitude Capital Associates, L.P. ("LCA") is the record holder of 14,737 shares of common stock. This report is filed jointly by Longitude Capital LLC ("Longitude Capital"), LVP, LCA and Juliet Tammenoms Bakker, all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors. Each of Longitude Capital and Ms. Tammenoms Bakker disclaim beneficial ownership of all securities except to the extent of their respective pecuniary interest therein.